Diagnosis and Treatment of Non-Neurogenic Overactive Bladder in Adults
Publication Date: September 1, 2019
Last Updated: March 14, 2022
Updated Guideline Statement
Clinicians may consider combination therapy with an anti-muscarinic and β3-adrenoceptor agonist for patients refractory to monotherapy with either anti-muscarinics or β3-adrenoceptor agonists. (Conditional, B)
322859
Recommendation Grading
Overview
Title
Diagnosis and Treatment of Non-Neurogenic Overactive Bladder in Adults
Authoring Organizations
American Urological Association
Society of Urodynamics Female Pelvic Medicine & Urogenital Reconstruction
Publication Month/Year
September 1, 2019
Last Updated Month/Year
January 31, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
The purpose of this guideline is to provide a clinical framework for the diagnosis and treatment of non-neurogenic overactive bladder (OAB).
Inclusion Criteria
Female, Male, Adult, Older adult
Health Care Settings
Ambulatory, Outpatient
Intended Users
Respiratory therapist, nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Treatment
Diseases/Conditions (MeSH)
D014549 - Urinary Incontinence
Keywords
Urinary Incontinence, overactive bladder, void dysfunction